PHARMACOTHERAPY OF PSORIASIS SUPPORT WITH ANTIPHOSPHOLIPID SYNDROME: ABC/VEN ANALYSIS OF ANTI-VIRAL DRUGS

Authors

  • Ihor Hayduchok Lviv Medical Institute LLC

DOI:

https://doi.org/10.53933/sspmpm.v1i1.4

Keywords:

pharmacotherapy, psoriasis, antiphospholipid syndrome, pharmacoeconomic, administrative and managerial decisions

Abstract

The aim was to research the pharmacotherapy of psoriasis with antiphospholipid syndrome based on ABC/VEN analysis of antiviral drugs. The materials of the study were the clinical and pharmacological groups for pharmacotherapy of psoriasis on the background of antiphospholipid syndrome. Regulatory, documentary, marketing, pharmacoeconomic, ABC/VEN research methods were used. Studied the clinical and pharmacological groups of the most drugs INN for basic pharmacotherapy of psoriasis have diagnostic codes of ATC classification L "Antineoplastic and immunomodulatory agents" and code M "Agents affecting the musculoskeletal system". In the article, the results of share of different medical forms of drugs for pharmacotherapy of psoriasis with antiphospholipid syndrome were shown. Matrix of the consolidated ABC-VEN analysis of drugs for pharmacotherapy of psoriasis with antiphospholipid syndrome was developed during the research. Shown the relevance and necessity of the chosen research topic because of a review of the scientific literature on epidemiology and pharmacotherapy. Marketing research of medicines were determined by assortment, country of origin, dosage forms, and registration certificates. Estimated that in the A/E categories, drugs coincide and are in a niche with an affordable share (17.04%). In terms of priority for pharmacotherapy of psoriasis on the background of antiphospholipid syndrome, a matrix of the combined ABC/VEN analysis was developed. The results of the study provide an opportunity to make administrative and managerial decisions in determining the pharmacotherapy of psoriasis with antiphospholipid syndrome to improve the use pharmaceutical provision for patients with systemic autoimmune diseases.

References

Psoriasis. World Health Organization. 30.05.2013. https://apps.who.int/iris/bitstream/handle/10665/172368/B133_R2-ru.pdf?sequence=1&isAllowed=y (Accessed 09 March, 2021).

Global report on PSORIASIS .World Health Organization. 2016. Geneva. 44 р. https://apps.who.int/iris/bitstream/handle/ 10665/204417/9789241565189_eng.pdf?sequence=1 (Accessed 11 March, 2021).

Psoriasis Statistics. National Psoriasis Foundation. USA. 10.08.2020 https://www.psoriasis.org/psoriasis-statistics/ (Accessed 25 March, 2021).

Yemchenko Y.O., Ishcheikin K.E., Kaidashev I.P. Analysis of the incidence and prevalence of psoriasis in Ukraine and Poltava region. Bulletin of VDNZU "Ukrainian Medical Dental Academy". 2014;14(3):72–76.

Abbud Aymen. Comparative analysis of comorbid conditions in patients with psoriasis, taking into account the sex of the subjects. Dermatovenereology. Cosmetology. Sexopathology. 2015;1-2:90–92.

Weinberg J.M. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis. Clin Ther. 2003;25(10):2487-505. DOI: 10.1016/s0149-2918(03)80313-2. DOI: https://doi.org/10.1016/S0149-2918(03)80313-2

Psoriasis therapy by Chinese medicine and modern agents / Shikang Meng, Zibei Lin, Yan Wang, Zhenping Wang (et all). Chin. Med. 2018;13:16 р. DOI: 10.1186/s13020-018-0174-0. DOI: https://doi.org/10.1186/s13020-018-0174-0

Network Pharmacology-Based Analysis on the Mechanism of Action of Ephedrae Herba-Cinnamomi Ramulus Couplet Medicines in the Treatment for Psoriasis / Shun Guo, Jin-Yong Zhou, Cheng Tan, Le Shi (et all). Med. Sci. Monit. 2021;27. DOI: 10.12659/MSM.927421. DOI: https://doi.org/10.12659/MSM.927421

Hayduchok I.G., Shapovalova V.O., Shapovalov V.V., Shapovalov V.V. Control regime of antibacterial drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with dual disorders. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020; 230–2020:6 p.

Hayduchok I.G., Shapovalova V.O., Shapovalov V.V., Shapovalov V.V. Control regime of drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with systemic diseases. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020; 225 – 2020: 6 p.

Shapovalova V.O., Zbrozhek S.I., Shapоvalov (Jr.) V.V., Shapovalov V.V. Coronavirus disease pandemia 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences (ISSN: 2581–5423). 2020. June 02, 2020; Published: July 01, 2020; 4(7): 61–68. DOI: https://doi.org/10.31080/ASPS.2020.04.0559

ATC-classification. Compendium on-line. http://compendium.com.ua/atc (Accessed 06 March, 2021).

Shapovalov (Jr.) V., Zbrozhek S., Gudzenko A., Shapovalova V., Shapovalov V. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018; 51(18):118-124.

Shapovalov (Jr.) V., Gudzenko A., Shapovalov V., Shapovalova V. Organizational and legal aspects of the use of pharmacoeconomic analysis of multivitamin complexes for pharmaceutical provision of military personnel. The Pharma Innovation Journal. 2018; 7(10):166–169.

National list of basic medicines. Resolution of the Cabinet of Ministers of Ukraine of 25.03.2009 №333. http://zakon4.rada.gov.ua (Accessed 14 March, 2021)

On approval of the twelfth issue of the State formulary of medicines and ensuring its availability. Order of the Ministry of Health of Ukraine dated 06.05.2020 №1075. http://zakon4.rada.gov.ua (Accessed 14 March, 2021).

Shapovalov (Jr.) V., Gudzenko A., Komar L., Butko A., Shapovalova V., Shapovalov V. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017; 65(2):23–29.

Shapovalov (Jr.) V., Gudzenko A., Shapovalova V., Osyntseva A., Shapovalov V. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017; 66(3):31–39.

Shapovalova V.A., Zbrozhek S.I., Shapovalov V.V., Shapovalov V.V. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Science (ISSN: 2581-5423). 2021; 4(1): 7 – 12. DOI: 10.3180/ASPS.2020.05.0651.

Order of the Ministry of Health of Ukraine dated 20.11.2015 № 762 "On approval and implementation of medical and technological documents for the standardization of medical care for psoriasis, including psoriatic arthropathy."

Guideline 00444. Psoriatic arthropathy. Author: Riitta Luosujärvi. Original text editor: Anna Kattainen. Date of last update: 2016-09-29.

Downloads

Published

2021-08-18

How to Cite

Hayduchok, I. (2021). PHARMACOTHERAPY OF PSORIASIS SUPPORT WITH ANTIPHOSPHOLIPID SYNDROME: ABC/VEN ANALYSIS OF ANTI-VIRAL DRUGS. SSP Modern Pharmacy and Medicine, 1(1), 1–12. https://doi.org/10.53933/sspmpm.v1i1.4

Issue

Section

Articles